Patent · US Active

NPY Y5 antagonist

US8115027B2 · kind B2 · utility

0Cited by
14References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2010
Grant dateFeb 14, 2012
Priority date
Expiry dateJul 2, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound or the formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.